Press Releases March 17, 2021 Process Development and Biological Evaluation of Antibody Drug Conjugate Based on a Novel Site-Specific Chemical Conjugation Platform Press Releases Related Articles July 8, 2026 Notice of Office Closure GeneDesign, Inc. – Osaka... June 23, 2026 Notice of Appointment of Directors GeneDesign, Inc. – Osaka... April 21, 2026 Impact of the Current Situation in the Middle East on Our Manufacturing Operations GeneDesign, Inc. – Osaka... April 16, 2026 Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing